Mersana Therapeutics, Inc. (MRSN)
28.15
+0.01
(+0.04%)
USD |
NASDAQ |
Dec 10, 13:17
Mersana Therapeutics Profit Margin (Quarterly): -68.53% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Day One Biopharmaceuticals, Inc. | -49.57% |
| Cidara Therapeutics, Inc. | -- |
| Cue Biopharma, Inc. | -346.6% |
| Scholar Rock Holding Corp. | -- |
| ETHZilla Corp. | -5.08K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -61.05% |
| Gross Profit Margin (Quarterly) | 99.25% |
| Operating Margin (Quarterly) | -67.68% |
| Return on Net Operating Assets | -1.25K% |